z-logo
open-access-imgOpen Access
Mutations Disrupting Selenocysteine Formation Cause Progressive Cerebello-Cerebral Atrophy
Author(s) -
Orly Agamy,
Bruria Ben Zeev,
Dorit Lev,
Barak Marcus,
Dina Fine,
Dan Su,
Ginat Narkis,
Rivka Ofir,
Chen Hoffmann,
Esther LeshinskySilver,
Hagit Flusser,
Sara Sivan,
Dieter Söll,
Tally LermanSagie,
Ohad S. Birk
Publication year - 2010
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2010.09.007
Subject(s) - atrophy , neuroscience , selenocysteine , medicine , pathology , biology , biochemistry , cysteine , enzyme
The essential micronutrient selenium is found in proteins as selenocysteine (Sec), the only genetically encoded amino acid whose biosynthesis occurs on its cognate tRNA in humans. In the final step of selenocysteine formation, the essential enzyme SepSecS catalyzes the conversion of Sep-tRNA to Sec-tRNA. We demonstrate that SepSecS mutations cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) in Jews of Iraqi and Moroccan ancestry. Both founder mutations, common in these two populations, disrupt the sole route to the biosynthesis of the 21st amino acid, Sec, and thus to the generation of selenoproteins in humans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom